Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon Apr 25, 2022 12:24pm
95 Views
Post# 34629264

RE:Stutters doesnt bash ate at all. Just mugsy

RE:Stutters doesnt bash ate at all. Just mugsy
Stutters wrote:


Oh ... I've hit a nerve.
So you were created to go after Mugsy ... interesting ... going to correct you again ...

You were going after Dan.
Then Pez upset you.
Then you couldn't figure out why I was so positive on the company.
Then I was your target.

Not my first roller coaster friend - obviously it's yours ... you have proven that you don't know how to deal with setbacks in pharma.  Ranting and raving doesn't move the price - development moves the price.

I'm betting the market has it wrong ... so I've been buying.
Would you really expect me to trash a company when I believe in our patents and ithat H2S discovery has a learning curve? 

All I asked is that we go to market to get cash - make bank - so we can continue with development.  The rest will follow nicely.  All roads still have exciting paths and we're learning so much in the process.

You don't have to agree.

This community would just like some honesty from you or you get ignored.  So ... who are you really ?  Which other alias?  I think I already nailed it and flustered you.  You're definately not at SH for the information and the conversations as you only visit us.

: )
<< Previous
Bullboard Posts
Next >>